Wegovy approved in China, but Novo Nordisk promises priority to existing patients amid shortages
Topline Ozempic maker Novo Nordisk confirmed Tuesday that its popular weight-loss drug Wegovy had been approved for sale in China, a major win for the Danish company that opens the door to a huge market, but the company told Forbes it will only launch there once it can guarantee supplies for those already using them … Read more
